Account
Inquiry
Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide has shown significant potential in clinical research for improving glycemic control in type 2 diabetes studies.
The compound works by simultaneously targeting both GIP and GLP-1 receptors, leading to increased insulin secretion and decreased glucagon release in a glucose-dependent manner. Research indicates promising results for both blood sugar regulation and weight management applications.
When you buy tirzepatide for research purposes, you receive a high-quality compound synthesized under strict quality control measures. The white powder form ensures easy handling and preparation for laboratory studies.
Important Note: This product is intended for research use only. Not for human consumption or diagnostic use. All researchers should follow appropriate safety protocols when handling this compound.
